The Institute of Biological Psychiatry (IBP) is a pioneering interdisciplinary research facility at the forefront of psychiatric research. As a leading biomedical psychiatric research and clinical biochemistry institute, we focus on the intersection between molecular biology, genomics, register research, and psychiatry. With over 30 experts from diverse academic backgrounds, our team is dedicated to uncovering the biological expressions of mental disorders and the genetic links to mental illness.

Headed by Professor and Research Director Thomas Werge, IBP is affiliated with the prestigious University of Copenhagen and is a key partner in the groundbreaking iPSYCH Initiative, the world's largest psychiatric research project. Since its founding in 1916, IBP has been a trailblazer in mental health research, contributing to the development of the dopamine hypothesis of psychosis and advancements in genetic counseling. Located at Denmark's largest psychiatric hospital, Sct.

Hans, we work alongside more than 350 in-patients, providing the highest level of care and innovation. Our research is conducted in collaboration with leading global research teams, national initiatives, and international consortia. We publish our discoveries in peer-reviewed journals, paving the way for further advancements and validation.

With our state-of-the-art facilities and experienced team, IBP is also the national reference center for genomic analysis and genetic counseling, particularly in child and adolescent psychiatry. We offer genetic screening programs to clinical departments throughout the country, utilizing genome-wide screening for chromosomal abnormalities. Discover the cutting-edge research and breakthroughs happening at the Institute of Biological Psychiatry.

Contact us today to learn more about our work and how we are transforming the field of psychiatry